Faculty of Medicine and Health Technology
Ashok Aspatwar is a Senior Researcher in the Faculty of Medicine and Health Technology, Tampere University, Finland. He studied bioinformatics and molecular biology at the Department of Bioinformatics, Tampere University and graduated in 2010. Subsequently, he continued his studies for a Ph.D. in Prof. Parkkila Group in the Department of Anatomy, School of Medicine, Tampere University. He obtained his Ph.D. in 2014, with a thesis on Function of Carbonic Anhydrases Related Proteins (CARPs) in zebrafish. He studied roles of CARPs VIII, X and XI using morpholino and CRISPR/Cas9 technology to inactivate the CARP genes in zebrafish model during embryonic development.
During his doctoral research, Dr. Aspatwar has developed keen interest on understanding the roles of α-carbonic anhydrases (α-CAs) in humans and β-CAs in Mycobacterium tuberculosis using different model organisms. After obtaining his doctoral degree, he worked in Infection Biology group headed by Dr. Mataleena Parikka at BioMediTech, University of Tampere. In the Infection Biology Group, he learnt to use Mycobacterium marinum a model mycobacterium that is a natural tuberculosis (TB) pathogen of zebrafish. Currently, Dr. Aspatwar uses M. marinum and zebrafish as model organisms to understand precise roles of β-CAs in the pathogenesis of TB and survival of bacterium in the host during latent phase of the disease.
In addition, Ashok Aspatwar is interested in developing novel drugs targeting β-CAs and hitherto unexplored pathways of M. tuberculosis. To achieve the goal, his department has been in collaboration with several national and international research groups who are involved in drug discovery and cell biology studies, eventually helping to get better insights into molecular mechanism of TB disease.
Phylogeny and expression of carbonic anhydrase-related proteins.
BMC molecular biology Mar, 2010 | Pubmed ID: 20356370
Inactivation of ca10a and ca10b Genes Leads to Abnormal Embryonic Development and Alters Movement Pattern in Zebrafish.
PloS one , 2015 | Pubmed ID: 26218428
Fluorinated benzenesulfonamide anticancer inhibitors of carbonic anhydrase IX exhibit lower toxic effects on zebrafish embryonic development than ethoxzolamide.
Drug and chemical toxicology Jul, 2017 | Pubmed ID: 27600313
β-CA-specific inhibitor dithiocarbamate Fc14-584B: a novel antimycobacterial agent with potential to treat drug-resistant tuberculosis.
Journal of enzyme inhibition and medicinal chemistry Dec, 2017 | Pubmed ID: 28629306
Zebrafish as a Model Organism for the Development of Drugs for Skin Cancer.
International journal of molecular sciences Jul, 2017 | Pubmed ID: 28718799
Identification and characterization of a novel zebrafish (Danio rerio) pentraxin-carbonic anhydrase.
PeerJ , 2017 | Pubmed ID: 29230365
An Update on the Metabolic Roles of Carbonic Anhydrases in the Model Alga Chlamydomonas reinhardtii.
Metabolites Mar, 2018 | Pubmed ID: 29534024
Carbonic anhydrase related protein expression in astrocytomas and oligodendroglial tumors.
BMC cancer May, 2018 | Pubmed ID: 29792187
Nitroimidazole-based inhibitors DTP338 and DTP348 are safe for zebrafish embryos and efficiently inhibit the activity of human CA IX in Xenopus oocytes.
Journal of enzyme inhibition and medicinal chemistry Dec, 2018 | Pubmed ID: 29909747
Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on and Studies.
Molecules (Basel, Switzerland) Nov, 2018 | Pubmed ID: 30413024
Catalytically inactive carbonic anhydrase-related proteins enhance transport of lactate by MCT1.
FEBS open bio Jul, 2019 | Pubmed ID: 31033227
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved